7-150951700-C-G
Variant summary
Our verdict is Pathogenic. The variant received 19 ACMG points: 19P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Very_Strong
The NM_000238.4(KCNH2):c.1693G>C(p.Ala565Pro) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 13/23 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A565T) has been classified as Uncertain significance.
Frequency
Consequence
NM_000238.4 missense
Scores
Clinical Significance
Conservation
Publications
- long QT syndromeInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- long QT syndrome 2Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
- short QT syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- short QT syndrome type 1Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
- Brugada syndromeInheritance: AD Classification: MODERATE, NO_KNOWN Submitted by: ClinGen, Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 19 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| KCNH2 | NM_000238.4 | c.1693G>C | p.Ala565Pro | missense_variant | Exon 7 of 15 | ENST00000262186.10 | NP_000229.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| KCNH2 | ENST00000262186.10 | c.1693G>C | p.Ala565Pro | missense_variant | Exon 7 of 15 | 1 | NM_000238.4 | ENSP00000262186.5 |
Frequencies
GnomAD3 genomes Cov.: 34
GnomAD4 exome Cov.: 34
GnomAD4 genome Cov.: 34
ClinVar
Submissions by phenotype
not provided Pathogenic:1
p.Ala565Pro (GCC>CCC): c.1693 G>C in exon 7 of the KCNH2 (HERG) gene (NM_000238.2). A missense variant that is likely pathogenic was identified in the KCNH2 gene. The A565P variant in has not been reported as a disease-causing mutation or as a benign polymorphism to our knowledge. The A565P variant is a semi-conservative amino acid substitution, which may impact secondary protein structure as these residues differ in some properties. This substitution occurs at a position that is conserved across species. In silico analysis predicts A565P is probably damaging to the protein structure/function. A mutations at this residue (A565T) and in nearby residues (W563G, W563C, L564P, C566G, C566S, C566F, I567T ) have been reported in association with LQTS (Kapplinger J et al., 2009), further supporting the functional importance of this residue and this region of the protein. Furthermore, A565P was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. Therefore, this variant is a strong candidate for a pathogenic mutation, however the possibility that it is a benign variant cannot be excluded. The variant is found in LQT panel(s). -
Cardiovascular phenotype Pathogenic:1
The p.A565P variant (also known as c.1693G>C), located in coding exon 7 of the KCNH2 gene, results from a G to C substitution at nucleotide position 1693. The alanine at codon 565 is replaced by proline, an amino acid with some highly similar properties. This alteration is located in the S5 domain of the central pore, and internal structural analysis predicts this alteration to be structurally deleterious (Long SB et al. Nature. 2007;450(7168):376-82). An alteration affecting the same amino acid (p.A565T, c.1693G>A) was detected in a cohort of patients sent for long QT syndrome genetic testing (Kapplinger JD et al. Heart Rhythm. 2009;6(9):1297-303). This variant was previously reported in the SNPDatabase as rs199473518. This variant was not reported in population based cohorts in the following databases: ExAC, NHLBI Exome Sequencing Project (ESP), and 1000 Genomes Project. In the ESP, this variant was not observed in 6503 samples (13006 alleles) with coverage at this position. This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at